(Q30047444)

25 May 2017

7

Zahir Amoura

1 reference

25 May 2017

1

Julien Haroche

1 reference

25 May 2017

author name string

Laurent Arnaud

2

1 reference

25 May 2017

Fleur Cohen-Aubart

3

1 reference

25 May 2017

Baptiste Hervier

4

1 reference

25 May 2017

Frédéric Charlotte

5

1 reference

25 May 2017

Jean-François Emile

6

1 reference

25 May 2017

publication date

16 February 2014

1 reference

Current Rheumatology Reports

25 May 2017

published in

1 reference

25 May 2017

volume

16

1 reference

25 May 2017

issue

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-014-0412-0

25 May 2017

exact match

0 references

cites work

Über Lipoidgranulomatose

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Scintigraphic diagnosis of Erdheim-Chester disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Variability in the efficacy of interferon-alpha in Erdheim-Chester disease by patient and site of involvement: results in eight patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Chemotherapy and interferon-alpha treatment of Erdheim-Chester disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

18F-fluorodeoxyglucose-positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Bone involvement in Erdheim-Chester disease: imaging findings including periostitis and partial epiphyseal involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Erdheim-Chester disease with prominent pericardial involvement: clinical, radiologic, and histologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Images in cardiovascular medicine. Cardiac involvement in Erdheim-Chester disease: magnetic resonance and computed tomographic scan imaging in a monocentric series of 37 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Bilateral adrenal infiltration in Erdheim-Chester disease. Report of seven cases and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Pulmonary involvement in Erdheim-Chester disease: a single-center study of thirty-four patients and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Erdheim-Chester disease: CT findings of thoracic involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Cerebral, facial, and orbital involvement in Erdheim-Chester disease: CT and MR imaging findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Erdheim-Chester disease: case report with multisystemic manifestations including testes, thyroid, and lymph nodes, and a review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Erdheim-chester disease presenting as bilateral clinically malignant breast masses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Treatment of Erdheim-Chester disease with cladribine: a rational approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Treatment of refractory Erdheim-Chester disease with double autologous hematopoietic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Response of histiocytoses to imatinib mesylate: fire to ashes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Imatinib mesylate for platelet-derived growth factor receptor-beta-positive Erdheim-Chester histiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Raf: a strategic target for therapeutic development against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Recurrent BRAF mutations in Langerhans cell histiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

BRAF inhibition in refractory hairy-cell leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Detection of an NRAS mutation in Erdheim-Chester disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

21 January 2018

Erdheim-Chester disease.

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

Tumor Necrosis Factor α As a Master Regulator of Inflammation in Erdheim-Chester Disease: Rationale for the Treatment of Patients With Infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0412-0

21 January 2018

Erdheim-Chester disease

1 reference

12 December 2020

BRAF mutations in Erdheim-Chester disease

1 reference

12 December 2020

Erdheim-Chester syndrome, presenting as hypogonadotropic hypogonadism and diabetes insipidus

1 reference

12 December 2020

Bilateral hydronephrosis in a patient with Erdheim-Chester disease

1 reference

12 December 2020

FDG-PET in the Erdheim-Chester disease: its diagnostic and follow-up role

1 reference

12 December 2020

Imaging of thoracoabdominal involvement in Erdheim-Chester disease

1 reference

12 December 2020

Immunohistochemical evidence of a cytokine and chemokine network in three patients with Erdheim-Chester disease: Implications for pathogenesis

1 reference

12 December 2020

Erdheim-Chester disease. Case report with autopsy findings

1 reference

12 December 2020

[An unusual breast tumor]

1 reference

12 December 2020

"Coated aorta": a new sign of Erdheim-Chester disease

1 reference

12 December 2020

Endocrine manifestations of Erdheim-Chester disease (a distinct form of histiocytosis).

1 reference

12 December 2020

Two enlarged kidneys: a manifestation of Erdheim-Chester disease

1 reference

12 December 2020

Erdheim-Chester disease: two cases of orbital involvement

1 reference

12 December 2020

[Erdheim-Chester disease]

1 reference

12 December 2020

Erdheim-Chester disease

1 reference

12 December 2020

Coexistence of localized Langerhans cell histiocytosis and cutaneous Rosai-Dorfman disease

1 reference

12 December 2020

Erdheim-Chester disease: a distinct lipoidosis or part of the spectrum of histiocytosis?

1 reference

12 December 2020

Erdheim-Chester disease in childhood: a challenging diagnosis and treatment

1 reference

12 December 2020

Erdheim-Chester disease: report on a case and new insights on its immunopathogenesis

1 reference

12 December 2020

Erdheim-Chester disease: a case report and literature overview

1 reference

12 December 2020

Orbital manifestations of Erdheim-Chester disease.

1 reference

12 December 2020

Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patients

1 reference

12 December 2020

High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation for adult histiocytic disorders with central nervous system involvement

1 reference

12 December 2020

Myocardial involvement in Erdheim-Chester disease

1 reference

12 December 2020

Successful treatment of Erdheim-Chester disease by 2-chlorodeoxyadenosine-based chemotherapy. Two case studies and a literature review

1 reference

12 December 2020

Combined Erdheim-Chester disease and Langerhans cell histiocytosis of skin are both monoclonal: a rare case with human androgen-receptor gene analysis

1 reference

12 December 2020

10.1007/S11926-014-0412-0

Identifiers

DOI

2 references

25 May 2017

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1204762

1043485938

0 references

1204762

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference